Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7EGU

Structure of human NNMT in complex with macrocyclic peptide X

7EGU の概要
エントリーDOI10.2210/pdb7egu/pdb
分子名称Nicotinamide N-methyltransferase, macrocyclic peptide X (3 entities in total)
機能のキーワードnicotinamide n-methyltransferase, transferase
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数2
化学式量合計30228.80
構造登録者
主引用文献Hayashi, K.,Uehara, S.,Yamamoto, S.,Cary, D.R.,Nishikawa, J.,Ueda, T.,Ozasa, H.,Mihara, K.,Yoshimura, N.,Kawai, T.,Ono, T.,Yamamoto, S.,Fumoto, M.,Mikamiyama, H.
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell.
Acs Med.Chem.Lett., 12:1093-1101, 2021
Cited by
PubMed Abstract: Nicotinamide -methyltransferase (NNMT), which catalyzes the methylation of nicotinamide, is a cytosolic enzyme that has attracted much attention as a therapeutic target for a variety of diseases. However, despite the considerable interest in this target, reports of NNMT inhibitors have still been limited to date. In this work, utilizing translated macrocyclic peptide libraries, we identified peptide as a novel class of NNMT inhibitors. Further exploration based on the X-ray cocrystal structures of the peptides with NNMT provided a dramatic improvement in inhibitory activity (peptide : IC = 0.15 nM). Furthermore, by balance of the peptides' lipophilicity and biological activity, inhibitory activity against NNMT in cell-based assay was successfully achieved (peptide : cell-based IC = 770 nM). These findings illuminate the potential of cyclic peptides as a relatively new drug discovery modality even for intracellular targets.
PubMed: 34267879
DOI: 10.1021/acsmedchemlett.1c00134
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.9 Å)
構造検証レポート
Validation report summary of 7egu
検証レポート(詳細版)ダウンロードをダウンロード

249524

件を2026-02-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon